(Q42600363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

editorial

0 references

title

Subjective effects of antipsychotic drugs and their relevance for compliance and remission (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Dieter Naber

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

Epidemiologia e Psichiatria Sociale

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

174-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Subjective effects of antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Subjective response to antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Subjective well-being and quality of life under atypical antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability.

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Treatment with neuroleptics: the patient's perspective

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Neuroleptic dysphoria: towards a new synthesis

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.

1 reference

https://api.crossref.org/works/10.1017%2FS1121189X00001238

7 January 2021

10.1017/S1121189X00001238

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18924553%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference